PFE•benzinga•
Pfizer Announced That The European Commission Has Granted Marketing Authorization For Hympavzi (marstacimab) For Treatment of Adults and Adolescents with Severe Hemophilia A or B Without Inhibitors
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 20, 2024 by benzinga